Matthew B. Murphy
General Counsel · Nautilus Biotechnology, Inc.
- 2025
- Mar 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew B. Murphy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AH Equity Partners Bio II, L.L.C. - $11.75M in NAUT purchases and sales in the last 12 months
- Kentaro Suzuki - $6K in NAUT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew B. Murphy?
Matthew B. Murphy is a corporate insider, tracked as General Counsel of Nautilus Biotechnology, Inc. (NAUT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Matthew B. Murphy last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 2 filings going back to 2025.
Has Matthew B. Murphy been buying or selling stock?
Recorded transactions: 1 open-market purchase ($13K) and 0 open-market sales across all tracked filings.
